SCHEMBL7724075

SCHEMBL7724075

COCCNC(=O)n1ccnc1

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.40
NAMPT P43490 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HPGD P15428 4/20 0.39
ALDH1A1 P00352 4/20 0.38
TSHR P16473 2/20 0.38
KDM4E B2RXH2 2/20 0.38
GAA P10253 2/20 0.38
GLA P06280 1/20 0.38
ATM Q13315 1/20 0.38
TDP1 Q9NUW8 3/20 0.38
HSD17B10 Q99714 1/20 0.38
MAPT P10636 1/20 0.38
NPC1 O15118 1/20 0.37
THRB P10828 1/20 0.37
RAB9A P51151 1/20 0.37
RECQL P46063 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6094890 0.91 SMN1; SMN2 (0.36) BCHENAMPTSMN1; SMN2HPGDALDH1A1
SCHEMBL5257422 0.81 QPCT (0.45) BCHENAMPTSMN1; SMN2ALDH1A1GAA
SCHEMBL2482514 0.81 THRB (0.37) SMN1; SMN2ALDH1A1TSHRGAATDP1
SCHEMBL15570675 0.80 SMN1; SMN2 (0.36) SMN1; SMN2ALDH1A1KDM4ETDP1
SCHEMBL17726997 0.80 ALDH1A1 (0.41) SMN1; SMN2ALDH1A1TSHRGAAMAPT
SCHEMBL693414 0.80 DUT (0.33) ALDH1A1GAA
SCHEMBL8631416 0.80 L3MBTL1 (0.36) SMN1; SMN2ALDH1A1HSD17B10MAPTNPC1
SCHEMBL11121639 0.80 L3MBTL1 (0.36) SMN1; SMN2ALDH1A1HSD17B10MAPTNPC1
SCHEMBL12031906 0.79 L3MBTL1 (0.33) SMN1; SMN2ALDH1A1TSHRGAATDP1
SCHEMBL18034386 0.79 ALDH1A1 (0.38) SMN1; SMN2ALDH1A1TSHRGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403805-B1 SUCH AS 1-((1-(3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL) CYCLOPROPYL)METHYL)-1,3-DIHYDRO-2H-IMIDAZOL-2-ONE FOR ALLERGIES, ATOPIC AND INFLAMMATORY DISEASES WHEREIN ACTIVITY OF PHOSPHODIESTERASE IS ALTERED JANSSEN PHARMACEUTICA N.V. (BE) 2002-06-11 US disclosed